Related Experiment Video
Updated: Jul 23, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Methodological quality and recommendations of hemophilia clinical practice guidelines: A scoping review
Carolina J Delgado-Flores1, David García-Gomero2, Liseth Pinedo-Castillo3,4
1Carrera de Farmacia y Bioquímica, Facultad de Ciencias de la Salud Universidad Científica del Sur Lima Perú.
Insights
Quality of hemophilia clinical practice guidelines (CPGs) varies, with inconsistent prophylaxis recommendations. Further development is needed for transparent, evidence-based decision-making in hemophilia care.
Area of Science:
- Hematology
- Clinical Practice Guidelines
- Evidence-Based Medicine
Background:
- Clinical practice guidelines (CPGs) are crucial for healthcare professionals managing hemophilia.
- Variations in CPG quality and recommendations necessitate rigorous assessment.
- This study focuses on hemophilia CPGs published between 2017 and 2021.
Purpose of the Study:
- To evaluate the methodological quality of hemophilia CPGs.
- To compare prophylaxis recommendations within these guidelines.
- To identify areas for improvement in CPG development for hemophilia.
Main Methods:
- Comprehensive literature search across multiple databases (PubMed, TripDatabase, etc.).
- Methodological quality assessment using the AGREE-II instrument.
- Comparative analysis of prophylaxis recommendations, including dose and initiation.
Main Results:
- Eleven hemophilia CPGs met inclusion criteria; 5 from upper-middle-income countries.
- Prophylaxis dose recommendations were inconsistent (low, intermediate, or high dose).
- Few CPGs provided justification for recommendations; no economic evaluations were performed.
Conclusions:
- Hemophilia CPGs exhibit suboptimal quality and inconsistent prophylaxis recommendations.
- Lack of justification and transparency hinders evidence-based decision-making.
- Improvements in CPG development are essential for reliable hemophilia care.
Background And Aims:
Hemophilia clinical practice guidelines (CPGs) play a vital role in guiding healthcare professionals' decisions. However, the quality and recommendations of CPGs for hemophilia may vary. This study aimed to assess the methodological quality of hemophilia CPGs published between 2017 and 2021 and compare their recommendations for prophylaxis using clotting factor concentrate.
Methods:
We conducted a comprehensive search for relevant CPGs in PubMed, TripDatabase, Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) International Guidelines Database, Google Scholar, and Google. We used the AGREE-II instrument to assess the methodological quality of each CPG and compared their recommendations for prophylaxis.
Results:
Of the 11 CPGs that met the inclusion criteria, 5/11 were developed in upper-middle-income countries, and 6/11 used the GRADE methodology. The primary prophylaxis dose recommendations varied among the CPGs, with 4/11 recommending a low dose, 6/11 recommending an intermediate or high dose, and 1/11 not issuing a recommendation. However, only 2/11 CPGs provided justification for their recommendations on initiation and dose, and no economic evaluations were conducted to support these recommendations.
Conclusion:
The quality of hemophilia CPGs is not optimal, with inconsistent recommendations for prophylaxis and a lack of justification for these recommendations. To ensure evidence-based and trustworthy recommendations, there is a need for transparency and improvement in the decision-making process of hemophilia CPGs.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

